Correlation Between NYSE Composite and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on NYSE Composite and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Reviva Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Reviva Pharmaceuticals
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NYSE and Reviva is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Reviva Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 90.87 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 133.52 times less risky than Reviva Pharmaceuticals. It trades about 0.14 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 28.00 in Reviva Pharmaceuticals Holdings on August 30, 2024 and sell it today you would lose (5.00) from holding Reviva Pharmaceuticals Holdings or give up 17.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
NYSE Composite and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Reviva Pharmaceuticals Holdings
Pair trading matchups for Reviva Pharmaceuticals
Pair Trading with NYSE Composite and Reviva Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| NYSE Composite vs. Delek Drilling | NYSE Composite vs. Helmerich and Payne | NYSE Composite vs. Waste Management | NYSE Composite vs. US Global Investors |
| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |